SpaceX IPO Sparks Market Optimism as Shares Surge 19% on Trading Debut 
Changchun Targets EV Growth as China’s Auto Industry Consolidation Accelerates 
UK Banks Report Surge in APP Fraud Losses as Pressure Mounts on Meta and Tech Platforms 
Roku Explores Sale Options as Interest Grows in Streaming and Ad Business 
SpaceX Stock Gets $175 Target as Analysts See Massive Growth Ahead 
Meta AI Strategy Faces Challenges as Zuckerberg Admits Mistakes in Internal Memo 
EngineAI Files for Hong Kong IPO Amid Rising Demand for AI and Robotics Stocks 
Elon Musk Becomes World's First Trillionaire After SpaceX IPO Surge 
Anthropic Restricts Global Access to AI Models After U.S. Security Review 
SpaceX IPO Set for Explosive Debut as Valuation Tops $2.2 Trillion 
Astera Labs and Rocket Lab Surge After Nasdaq-100 Inclusion Announcement 
Woodside Energy Acquires PetroChina’s Browse Stake, Expands Position in Major Australian Gas Project 
Hanmi Semicon Shares Surge After $33 Million SpaceX Investment 
ByteDance Eyes Iluvatar, Baidu AI Chips Amid China’s AI Push 
Adobe Beats Q2 2026 Estimates, Raises Full-Year Outlook as AI Revenue Surges Despite Stock Drop 
Oracle Stock Falls Despite Earnings Beat as Company Plans $40 Billion Financing for FY2027 
Anthropic Officials Meet White House Over AI Model Outage 
Samsung Electonics’ Galaxy smartwatches are being put in the spotlight after a recent study shows it can help people suffering from Parkinson’s disease. It was revealed on Wednesday, Sept. 15, that the smart gadget’s blood pressure monitoring feature is very useful for patients.
The Samsung Galaxy smartwatches are equipped with various health and fitness features and its blood pressure monitoring was especially found to be beneficial. According to Yonhap News Agency, a study was conducted at the Samsung Medical Center based in Seoul, and researchers found that the BP function in the watch may help people with Parkinson’s disease in terms of effective management of orthostatic hypotension which is a type of low blood pressure typically brought about by blood vessels that failed to constrict.
The study led by Dr. Jin Whan Cho and Dr. Jong Hyeon Ahn has been titled the “Validation of Blood Pressure Measurement Using a Smartwatch in Patients With Parkinson's Disease,” and it was published in Frontiers in Neurology, a medical journal for research reports, in June.
In the report, researchers were said to have compared blood pressure measurement data taken from the Samsung Galaxy Watch3 and the other was measured by using a sphygmomanometer. This was done to compare the accuracy of the results and it showed that both devices yielded similar measurements.
“Orthostatic hypotension is a common and challenging symptom that affects people living with PD. But it is hard to screen just by observing symptoms, and the problem may go undetected when measuring BP,” the research team said in a separate press release that was posted by Samsung. “If we could use a smartwatch to measure patients’ BP regularly and detect potential issues at an early stage, it would really help treat and manage PD.”
The study was carried with the participation of 56 patients who were fitted with Galaxy Watch3 on one arm while the sphygmomanometer was put on the other. All the patients underwent blood measure testing three times, using the two devices.
Meanwhile, Samsung’s smartwatches lineup including Galaxy Watch3, Galaxy Watch Active2, and Galaxy Watch4 all have a blood pressure monitoring feature. The BP is being measured through pulse wave analysis that is tracked with Heart Rate Monitoring sensors.
